Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LEXAPRO
- Home Transcutaneous Electrical Acustimulation (TEA)
- Chinese Longitudinal and Systematic Study of Bioplar Disorder
- Aβ Dynamics in LLMD
- Adjunctive Game Intervention for Anhedonia in MDD Patients
- Antidepressant Response in Older Adults With Comorbid PTSD and MDD
- Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)
- Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram
- Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
- Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
- Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
- The Role of PKC Activation in the Immune-inflammatory Mechanism of Major Depressive Depression
- Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression
- Treating Depression With Transcutaneous Electrical Cranial-auricular Acupoint Stimulation (TECAS).
- Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.
- Escitalopram and Language Intervention for Subacute Aphasia
- Contact: Developing New Clinical Management Strategies
- A Study Utilizing Escitalopram in Glioma Patients
- A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on Depression
- Biomarkers of Antidepressant Response and Suicidal Events in Depressed Youth
- A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
- Anxiety and Depression in Epilepsy: A Pilot Treatment Study
- Anxiety and Depression in Epilepsy: A Treatment Study
- Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders
- A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol
- Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)
- Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
- Escitalopram for Agitation in Alzheimer's Disease
- Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer
- Neurofunctional Predictors of Escitalopram Treatment Response in Adolescents With Anxiety
- Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators
- Study of Neural Responses Induced by Antidepressant Effects
- Advancing Personalized Antidepressant Treatment Using PET/MRI
- Adjunctive Treatment of Major Depression Utilizing Auricular Acupuncture
- Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth
- Exercise and Pharmacotherapy for Anxiety in Cardiac Patients
- Connectivity Affecting the Antidepressant REsponse Study
- Study of Drug Combination on Pharmacokinetics in Healthy Volunteers
- SSRI Study for Functional Dyspepsia (SS)
- Developing New Clinical Management Strategies
- Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fed Condition
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fasting Condition
- Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
- Mechanisms of Antidepressant Non-Response in Late-Life Depression
- Brain Aging and Treatment Response in Geriatric Depression
- Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment
- An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms
- A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression
- Serotonergic Modulation of Motor Function in Subacute and Chronic SCI
- Neurobiological Bases of Placebo Response in Major Depressive Disorder
- Algorithm Guided Treatment Strategies for Major Depressive Disorder
- Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI)
- Bioequivalence Study of Escitalopram Tablets 10 mg
- Double-Blind Treatment of Major Depressive Disorder With Vilazodone
- Emotional and Cognitive Control in Late-Onset Depression
- Modafinil - Escitalopram Study for Cocaine Dependence
- Lexapro®'s Efficacy After Dose Escalation in Remission Study
- The Effects of Escitalopram on Cytokines
- Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder
- Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord Injury
- Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)
- Exploring Biomarkers for Depression
- Brain Imaging and Treatment Studies of the Night Eating Syndrome
- Influence of Escitalopram on Fear Conditioning
- Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
- Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions
- Investigation of Tibolone and Escitalopram in Perimenopausal Depression
- Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction
- Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
- Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder
- Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response
- Lexapro for Major Depression in Patients With Epilepsy
- Circadian Effects of Escitalopram
- Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
- Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
- Biomarkers for Outcomes In Late-life Depression (BOLD)
- Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype
- A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers
- Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress Disorder
- Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder
- Escitalopram (Lexapro) for Depression MS or ALS
- Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
- Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression
- Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients
- Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression
- Aging Brain Changes, Executive Dysfunction and Depression
- Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)
- MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife Women
- Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS
- Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care Unit
- A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression
- Escitalopram (Lexapro) for the Treatment of Postpartum Depression
- The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia
- Brain Effects of Escitalopram and Citalopram Using fMRI
- Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression
- Neurotrophic Factors and Depression
- Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
- Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression
- Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder
- Treatment Response of Geriatric Depression
- fMRI Studies of Emotional Brain Circuitry in People With Major Depression
- Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics
- Clinical Neurobiology of Serotonin and Addiction
- Study of Brain Response to Emotional Pictures Using a Magnetic Resonance Imaging (fMRI) While on Escitalopram
- Progression Delaying Effect of Escitalopram in Alzheimer's Disease
- International Study to Predict Optimised Treatment - in Depression
- Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS)
- The Effect of Escitalopram on the Pharmacokinetics and Pharmacodynamics of Tramadol in Healthy Subjects
- Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg
- Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg
- Combination Lexapro and Massage for Treatment of Depression in Older Adults
- Psychotherapy and Pharmacotherapy in Dissociative Disorders
- Brain Mechanisms and Targeting Insomnia in Major Depression
- ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder
- Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features
- Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults
- Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy
- Responses of Myocardial Ischemia to Escitalopram Treatment
- Efficacy of Escitalopram in the Treatment of Internet Addiction
- Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment
- Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study
- Does Dual Therapy Hasten Antidepressant Response?
- Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression
- Brain GABA Levels and Treatment Response in Major Depressive Disorder
- Wellbutrin XL Effects on SSRIs Induced Changes
- Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment
- Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism
- Galantamine Augmentation of Escitalopram for Treatment of Depression
- Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome
- PACEPro - Mood Management Pilot
- Antidepressant Safety in Kids Study
- Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication
- Imaging Predictors of Treatment Response in Depression
- Aripiprazole and Lexapro Drug Interaction Study
- Biological Markers of Response to Treatment in Major Depressive Disorder
- Identifying Factors That Predict Antidepressant Treatment Response
- Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
- Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)
- Treatment of Depression Following Multiple Brain Tests
- Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro
- Lexapro in the Treatment of Patients With Postpartum Depression
- Escitalopram Treatment of Patients With Agitated Dementia
- Essential Fatty Acids for Major Depression
- Functional Dyspepsia Treatment Trial
- Medications for the Treatment of Dysthymic Disorder and Double Depression
- Impact of Caregiver Depression on Asthma in the Child
- Escitalopram in the Treatment of Dysthymic Disorder, Double Blind
- Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)
- Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in Depression
- Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder
- Depression-Diabetes Mechanisms: Urban African Americans
- Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram
- Antidepressant Medication Plus Donepezil for Treating Late-life Depression
- Augmenting Antidepressant Treatment With Interpersonal Psychotherapy for Treating Late-life Depression
- Depression, Epinephrine, and Platelet Function
- Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
- Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment
- Drug Therapy for Generalized Anxiety Disorder Among the Elderly
- Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression
- Lexapro and Pramipexole and to Treat Major Depression
- Preventing Post-Stroke Depression
Clinical trials list
click for details